Chronic Inflammation: The Hidden Cost of Aging

Chronic inflammation is responsible for three out of every five deaths worldwide. Not acute infection, not sudden injury, but the slow, silent accumulation of low-grade immune activation that most people never feel until it has already shaped their biology for years. This is the paradox at the center of modern preventive health: the most consequential driver of how you age is also the hardest to see, the hardest to measure, and the easiest to ignore.

The challenge is not awareness. Most health-conscious adults understand that inflammation is "bad." The challenge is precision. Without a reliable way to measure chronic inflammation as distinct from the acute inflammatory signals that dominate standard blood panels, there is no way to know whether your diet, exercise, sleep, or medical interventions are actually working at the biological level that matters. You are navigating without instruments.

This article explains what chronic inflammation actually is, why it accelerates biological aging, why most existing biomarkers miss it, and how glycan-based measurement changes what is possible, both for individuals tracking their own health and for clinicians building longitudinal preventive care. It also covers what you can do to reduce chronic inflammation and how to measure whether those efforts are having a real biological effect.

What Is Chronic Inflammation and Why Is It Different from Acute Inflammation?

Inflammation is a fundamental biological process that manifests in two distinct forms: acute and chronic. Understanding the difference is not academic, it instead determines which biomarkers are useful and which are not.

Acute Inflammation: The Immune System Working as Designed

Acute inflammation is the body's immediate defense against injury, infection, and damage. It is fast, localized, and self-limiting. When you cut your finger or fight off a virus, the immune system mounts a targeted response, resolves the threat, and stands down. This is inflammation working as designed.

Chronic Inflammation: When the Response Never Switches Off

Chronic inflammation is what happens when that process does not resolve, or when it activates without any infectious trigger at all. It is a persistent, low-grade immune activation, sometimes called sterile inflammation, because it can be initiated not by bacteria or viruses but by damage-associated molecular patterns (DAMPs): excess glucose, cholesterol crystals, and cellular debris. The inflammatory profile it produces, such as elevated cytokines, chemokines, and acute phase proteins, is quieter than acute inflammation, but it never switches off.

Chronic inflammation can last from weeks to years and decades if unaddressed. It is usually asymptomatic. That is precisely what makes it dangerous: it accumulates silently, damaging tissues and organs over time, long before any clinical symptom appears.

What Drives Chronic Inflammation?

The Three Main Categories of Drivers

The drivers of systemic chronic inflammation fall into three broad categories. The primary contributor is age itself, because inflammation increases with aging in a process called inflammaging. Chronic infections and microbiome dysbiosis also drive systemic inflammation. And critically, unhealthy behaviors, such as smoking, physical inactivity, poor diet, high adiposity, are significant contributors, as are psychological stress, disturbed sleep, social isolation, and exposure to environmental toxicants.

How Visceral Fat Perpetuates the Inflammatory Cycle

Visceral and ectopic fat illustrate the mechanism clearly. Adipose tissue secretes pro-inflammatory molecules including interleukin-6 and TNF-alpha. As fat cells increase in size and number, those located deeper in tissue receive insufficient blood flow, triggering hypoxia and oxidative stress that further drives inflammation. Macrophages within visceral fat can shift from an anti-inflammatory (M2) to a pro-inflammatory (M1) profile, perpetuating the cycle. The downstream consequences include cardiovascular disease, insulin resistance, and type 2 diabetes.

Inflammaging: How Chronic Inflammation Accelerates Biological Aging

Inflammaging is the accumulation of low-grade chronic systemic inflammation that occurs as we age. It is now recognized as one of the twelve Hallmarks of Aging, and it does not stand alone.

The Biological Mechanisms Behind Inflammaging

Two mechanisms have been proposed to explain why inflammation increases with age. The first is mitochondrial dysfunction, which leads to increased reactive oxygen species and oxidative stress. The second is a decline in autophagy, which is the cellular process by which the body clears dead cells and their contents. It allows inflammatory debris to accumulate. Both feed back into the inflammatory cycle.

Inflammaging is also interconnected with other hallmarks: epigenetic alterations, cellular senescence, and disabled autophagy all tie into chronic inflammation. This is why chronic inflammation sits in the background of cardiovascular disease, metabolic disease, neurological diseases, autoimmune conditions, and endocrine imbalance. It is not a single disease mechanism, but the shared biological terrain on which multiple age-related diseases develop.

Atherosclerosis: Chronic Inflammation in Action

Atherosclerosis is a clear example. High blood pressure and other factors damage blood vessel walls, triggering an inflammatory response. Macrophages on site take up oxidized LDL cholesterol and form foam cells, which secrete inflammatory molecules that promote atherosclerotic plaque growth and arterial narrowing. This buildup creates rupture risk and subsequent clot formation — the mechanism behind heart attacks and stroke. Chronic inflammation does not just accompany cardiovascular disease; it precedes and drives it.

"In many inflammatory diseases, IgG glycans change up to a decade before people get diagnosed with a disease. These molecular changes happen very early, and with time, they become a disease. What we also know is that some lifestyle interventions which are known to decrease the risk of a disease also change glycans. So we hope that glycans can be intermediate endpoints — early things which you can measure to predict whether there will be improvement in disease prevention or even mortality prevention."

— Prof. Gordan Lauc, Chief Scientific Officer, GlycanAge; Professor of Biochemistry and Molecular Biology, University of Zagreb

Elevated inflammatory markers predict higher mortality risk. Inflammaging is a leading contributor to three out of five deaths worldwide. These are not abstract statistics, but the biological stakes of leaving chronic inflammation unmeasured.

How Chronic Inflammation Connects to Disease: What the Research Shows

Chronic inflammation is not a risk factor for one disease, but the shared mechanism underlying most of the conditions that cause premature death and disability. GlycanAge research, built on over 30 years of glycan science, has documented IgG glycan changes occurring six to ten years before clinical disease diagnosis across multiple disease categories.

Cardiovascular Disease

Systemic inflammation drives the initiation and progression of atherosclerosis, coronary artery disease, hypertension, and myocardial infarction. IgG glycans show a significant association with the Atherosclerotic Cardiovascular Risk Score (ASCVD) and have been shown to predict cardiovascular events years before diagnosis.

Metabolic Disease

Glycan changes associated with insulin resistance and type 2 diabetes have been detected up to ten years before clinical diagnosis. Research published in peer-reviewed journals has shown that plasma N-glycome deterioration occurs continuously as metabolic dysfunction approaches, providing a predictive window that standard glucose markers cannot offer. Metabolic conditions for which IgG glycan changes have been documented in the peer-reviewed literature also include chronic kidney disease and obesity-related metabolic dysfunction, conditions where glycan profiling adds predictive value beyond standard metabolic markers.

Neurological Disease

Chronic inflammation is a shared contributing mechanism across Alzheimer's disease, Parkinson's disease, and motor neuron disease (ALS), and pro-inflammatory IgG glycan changes have been documented across all three conditions. Neuroinflammation, which is the sustained immune activation within the central nervous system, drives neuronal damage and accelerates cognitive decline. Glycan biomarkers have been associated with Alzheimer's disease and Parkinson's disease in published research.

Autoimmune Conditions

Rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease (both Crohn's disease and ulcerative colitis), and ANCA-associated vasculitis all show characteristic IgG glycan changes. Because glycans are functional regulators of immune activity, not merely passive markers, they are both indicators of immune dysregulation and active participants in the autoimmune process.

Endocrine Imbalance

Menopause and andropause are associated with sharp shifts in glycan profile. Estrogen has a regulatory effect on IgG glycosylation, which is why the menopausal transition often produces a rapid increase in biological age, sometimes by more than a decade within a short window. This is one of the clearest demonstrations that hormonal change and immune aging are directly connected.

For clinicians, this disease breadth is the reason a chronic inflammation biomarker has more diagnostic utility than condition-specific markers. Chronic inflammation is the upstream signal. Measuring it early, before the downstream condition has taken hold, is the core of genuine preventive medicine.

Why Most Inflammation Biomarkers Miss the Point

The Problem with Standard Inflammatory Markers

If chronic inflammation is this consequential, why is it so rarely measured well? The answer lies in what most available biomarkers actually capture.

Standard inflammatory markers, such as TNF-alpha, ESR, high-sensitivity CRP, fibrinogen, ferritin, white blood cell count, are measures of acute inflammation. They are useful for detecting active infection, injury, or acute disease flares. But they are heavily skewed by whatever acute inflammatory activity is happening in the body at the moment of the blood draw, and they tend to change only when disease has already taken hold. For the purpose of identifying chronic disease risk early, when intervention can still make a meaningful difference, they are the wrong instrument.

"The most valuable thing about glycans is that they respond to interventions. I can say, look, I'm saving healthy years of my life. And then in a difficult period, my glycan age can accelerate — in a year I could lose ten years. Normally, our early warning is a heart attack, a stroke, a diabetes diagnosis. But if only biomarkers are moving in that direction, there is still no tissue damage — everything is still more or less fine. You fix it and hopefully you will never develop that disease."

— Prof. Gordan Lauc, Chief Scientific Officer, GlycanAge; Professor of Biochemistry and Molecular Biology, University of Zagreb

What a Reliable Chronic Inflammation Marker Needs to Do

What is needed is a marker that changes well before disease appears, that measures chronic inflammation specifically, and that is stable enough to distinguish real biological change from day-to-day fluctuation. Signaling molecules such as interleukin-1 are the first responders in the inflammatory cascade. Acute phase reactants like CRP follow. These are valuable in acute clinical contexts, but they are not designed to track the slow, persistent immune activation that defines inflammaging.

The five categories of currently available inflammation biomarkers are signaling molecules, acute phase reactants, CBC elements, organ-specific markers, and newer generation markers. They all have their place. But for measuring chronic inflammation as a driver of biological aging, the most informative signal comes from a different layer of biology entirely.

Glycans: The Biomarker That Measures Chronic Inflammation Directly

What Are Glycans?

Glycans are complex sugars (carbohydrates) present on the surface of virtually every cell in the human body and attached to the majority of proteins. They function as a biological language, enabling cells and proteins to communicate with each other. They are not passive structural molecules and they actively regulate immune function, inflammatory pathways, and cellular behavior.

How IgG Glycans Reflect Chronic Inflammation

The key connection to chronic inflammation runs through Immunoglobulin G (IgG), the most abundant antibody in human blood. IgG plays a central role in immune processes including antigen neutralization, phagocytosis, complement activation, and antibody-dependent cell-mediated cytotoxicity. Attached to each IgG molecule are multiple glycans that fine-tune how IgG functions. Some glycan combinations activate inflammatory pathways, making them pro-inflammatory. Others suppress those pathways, making them anti-inflammatory.

The overall profile of IgG glycans in a person is called the IgG glycome, and it directly reflects the level of chronic inflammation in the body. As a person ages, the IgG glycome undergoes striking changes: the frequency of pro-inflammatory glycans increases, and anti-inflammatory glycans decline. This predictable pattern of change enabled the development of the first biological age biomarker based solely on glycans — the glycan clock, first published in 2013 and commercially available since 2019. You can read the full science behind this on the GlycanAge science page.

Why IgG's Three-Week Half-Life Matters

IgG glycan changes are associated not only with aging but with the presence of disease and unhealthy lifestyle, making them a biomarker for personalized medicine. Critically, IgG has a half-life of approximately three weeks. This means GlycanAge does not capture a single moment in time, but reflects the chronic inflammatory state accumulated over weeks, filtering out the daily fluctuations that make acute markers unreliable for this purpose.

Traditional markers like CRP are short-lived molecules, often reflective of acute inflammation. GlycanAge, by measuring IgG glycosylation, provides a more precise evaluation of chronic inflammation and therefore the risk of chronic disease. And because IgG renews on a three-week cycle, GlycanAge can also track changes over time, capturing how lifestyle habits and medical interventions are shifting the inflammatory landscape.

GlycanAge vs. Epigenetic Clocks

GlycanAge has also been validated in comparison to epigenetic biological age clocks. Research has shown that repeated measurements of epigenetic clocks in the same individual can vary by up to ten years even without any meaningful biological change, making it difficult to distinguish real physiological shifts from measurement noise. GlycanAge demonstrates low intra-individual variability and high technical reproducibility, which is essential for tracking the impact of interventions over time.

What Your GlycanAge Result Tells You

The GlycanAge test analyzes 29 different glycan structures from a blood sample and groups them into five indexes that together reflect your chronic inflammatory state and biological age.

The Three Primary Indexes

Primary indexes are used to calculate your biological age:

• Glycan Shield (S): Anti-inflammatory. Reflects the presence of sialic acid on IgG. Higher values are protective.

• Glycan Youth (G2): Anti-inflammatory. Reflects the presence of two galactose molecules. Declines with age and stress-driven immune aging.

• Glycan Mature (G0): Pro-inflammatory. Reflects the absence of galactose. Increases with age, disease, and poor lifestyle.

The Two Supportive Indexes

Supportive indexes are not used in the age calculation but are clinically informative:

• Glycan Median (G1): Presence of one galactose; associated with lifestyle patterns and specific disease types.
  
  

• Glycan Bisection (B): Presence of bisecting GlcNAc; linked to stress physiology, autonomic dysregulation, and cardiovascular instability.

How the Biological Age Score Is Calculated

The biological age score is calculated by combining the primary indexes and comparing the result against a healthy population baseline of individuals aged 20 to 80. A biological age lower than chronological age indicates the immune system is functioning in a biologically younger state. A higher biological age signals accelerated immune aging driven by chronic inflammation.

What the Indexes Mean for Clinical Practice

For clinicians, the five indexes go beyond the single age number. They give directionality for treatment: low Glycan Shield often points to diet and nutrition; low Glycan Youth alongside elevated Glycan Mature is the classic pattern of chronic stress and recovery deficit (a profile seen frequently in high-demand professionals); elevated Glycan Bisection is associated with cardiovascular instability and autonomic strain. Each profile guides where intervention effort should focus.

How to Reduce Chronic Inflammation: What the Evidence Supports

Chronic inflammation is not an inevitable background condition that simply accumulates with age. It is driven by modifiable behaviors, and research using glycan-based biological age measurement has demonstrated that targeted interventions can produce measurable reductions in biological age within three to six months.

Diet

An anti-inflammatory dietary pattern, which is high in diverse plant foods, omega-3 fatty acids (EPA/DHA), fiber, and polyphenols; low in ultra-processed foods, refined sugars, and excess saturated fat, supports a shift toward anti-inflammatory glycan profiles. Omega-3 supplementation at 1–2 g/day has shown modest but measurable effects on IgG glycan structures, specifically reducing bisecting GlcNAc modifications. Diversity of plant intake appears particularly influential on gut microbiome composition, which in turn affects systemic inflammatory tone.

"I'm a doctor who has transferred from prescribing pills to prescribing lifestyle. That's really at the core of happy, healthy, long living. I measure biological age in all of my clients now as a critical piece of data that we should all be mapping to. Using data to drive that determination to change your lifestyle — and having accurate, personalized data — is so, so important."

— Dr. Alka Patel, GP & Lifestyle Medicine Doctor, Author and Longevity Specialist

Exercise

Moderate regular exercise reduces pro-inflammatory glycans and increases digalactosylated and sialylated glycan structures, which are the anti-inflammatory markers measured by Glycan Youth and Glycan Shield. A published clinical trial using the GlycanAge index confirmed that regular moderate physical activity decreases biological age and reduces the inflammatory potential of IgG. The relationship is non-linear: while recreational and active exercisers show favorable glycan profiles compared to inactive individuals, professional athletes in high-load training show glycan patterns resembling those seen in sedentary or older populations. Recovery is as important as activity volume.

Sleep and Circadian Rhythm

Elevated Glycan Bisection, a marker of stress physiology and autonomic dysregulation, improves with better sleep quality and recovery. Circadian disruption, including shift work, social jet lag, and irregular sleep timing, is a significant but underrecognized driver of chronic immune activation. Consistent sleep-wake schedules, reduced blue light exposure at night, and time-restricted eating all support circadian alignment and glycan profile improvement.

Stress Management

Psychological stress leaves measurable imprints on the IgG glycome. PTSD, social isolation, and chronic workplace stress are each associated with characteristic glycan shifts, which is a finding documented across multiple published studies. Practices that reduce autonomic stress load, including structured recovery, vagal tone activation, and time in nature, support glycan normalization over time.

Hormonal Health

Estrogen has a direct regulatory effect on IgG glycosylation. The sharp biological age increase observed during menopause, driven by declining estrogen, can be mitigated or reversed with appropriately managed hormone replacement therapy. For women navigating perimenopause and menopause, GlycanAge provides an objective measure of whether hormonal interventions are translating into real changes in immune aging.

Supplements

Evidence for targeted supplementation remains more limited than for the lifestyle factors above, but certain micronutrients, including vitamin D3 with K2, magnesium glycinate, and omega-3 fatty acids, have documented roles in immune regulation and inflammatory modulation. Zinc also plays a role in immune function, though evidence around its effects on IgG glycan profiles is mixed and supplementation at excess levels may have unintended effects on galactosylation.

Metformin has been explored as a potential geroprotective agent, but GlycanAge's own published research found it did not significantly affect biological age or IgG glycan profiles in non-diabetic individuals. Preliminary data suggests possible benefits in people with type 2 diabetes or insulin resistance, though this has not yet been confirmed in peer-reviewed research. This illustrates precisely why GlycanAge retesting matters, as individual responses vary, and objective measurement is the only way to know whether any intervention is working.

For clinicians, this intervention landscape means that GlycanAge is most useful not as a one-time snapshot but as a longitudinal tracking tool. Baselining before an intervention, then retesting at three to six months, provides objective evidence of biological response that changes the clinical conversation and supports patient adherence.

Putting It Into Practice: What This Means for You and Your Patients

Understanding chronic inflammation conceptually is one thing. Measuring it, and acting on what you find, is another.

For Health-Conscious Individuals

If you are making changes to your diet, exercise, sleep, stress management, or taking supplements or hormone therapy, you need a biomarker that can tell you whether those changes are working at the level of chronic inflammation. Standard blood panels will not show you this. Epigenetic clocks introduce substantial measurement variability. Glycan-based biological age testing gives you a stable, reproducible signal that can track real biological change over time.

"We should be proactive, not reactive. We should go for prevention rather than cure — we should go for the first cell rather than the last cell. In the future, we will not be treating disease by targeting its end stage, but by trying to reduce the stress that causes its appearance in the first place. If we can find those early stress markers, we can show the success of a new model."

— Prof. Azra Raza, Professor of Medicine & Director of the MDS Center, Columbia University; Author, The First Cell

Explore GlycanAge for personal use →

For Clinicians

Chronic inflammation is the shared mechanism underlying cardiovascular disease, metabolic disease, neurological disease, autoimmune conditions, and endocrine imbalance. Measuring it before disease appears, not after, is the foundation of genuine preventive medicine. The goal is a biomarker that changes way before disease happens, when a significant difference can still be made. GlycanAge is designed precisely for that window.

Integrate GlycanAge into your practice →

How the Test Works

The GlycanAge test requires a blood sample that can be collected at your doctor's office or via a kit sent to your home. Sampling requires four drops of blood, and instructions and everything needed for taking the sample are provided in the kit. Lab analysis usually takes between two to three weeks, after which results are delivered to your personal dashboard. Once your results are ready, you can book a 1:1 call with a longevity specialist to better understand them and receive a personalized health optimization plan. Regular retesting allows you to track how lifestyle changes and interventions are influencing your glycan age over time.

Integrating GlycanAge Alongside Existing Blood Panels

For practitioners, GlycanAge integrates naturally alongside existing blood panels. It does not replace standard markers, rather it adds the chronic inflammatory and immune-aging layer that standard panels cannot capture. Baselining a patient before initiating an intervention, then retesting after meaningful lifestyle or therapeutic changes, gives you objective evidence of biological response. That evidence changes the clinical conversation. If a patient is undergoing significant interventions, such as new therapies, medication adjustments, or substantial lifestyle modifications, an earlier retest may be appropriate to provide more immediate feedback on how these changes are influencing their glycan age.

The Measurement Gap Is Closeable

Chronic inflammation is the most consequential driver of biological aging, the shared mechanism behind the diseases that cause most premature deaths, and, until recently, the hardest thing in preventive health to measure reliably. That gap is now closable.

The science is clear: inflammaging is not an inevitable background process you simply accept. It is driven by modifiable behaviors, measurable through glycan biomarkers, and responsive to targeted interventions. The question is no longer whether chronic inflammation can be measured, but whether you are measuring it.

If you are ready to see your biological age and understand what your immune system is actually doing, order a GlycanAge test kit and book your 1:1 result interpretation call.

Order your GlycanAge test → Shop GlycanAge

If you are a clinician looking to integrate chronic inflammation measurement into your preventive care workflow, the Healthcare Providers page outlines how GlycanAge fits into clinical practice, from baselining to intervention monitoring.

Integrate GlycanAge into your practice → For Healthcare Providers

Frequently Asked Questions

What is the difference between chronic inflammation and acute inflammation?

Acute inflammation is a short-term immune response to injury or infection that resolves once the threat is cleared. Chronic inflammation is a persistent, low-grade immune activation that can last months to decades, often without any symptoms, and is strongly associated with accelerated biological aging and increased risk of cardiovascular disease, type 2 diabetes, and neurological conditions.

What is inflammaging?

Inflammaging is the progressive accumulation of low-grade systemic chronic inflammation that occurs as we age. It is one of the twelve official Hallmarks of Aging and is linked to virtually all major age-related diseases, including cardiovascular disease, metabolic syndrome, neurodegeneration, and autoimmune conditions.

Can chronic inflammation be measured with a standard blood test?

Standard inflammatory blood tests, including CRP, ESR, ferritin, and white blood cell count, primarily detect acute inflammation and are most useful for identifying active infections or disease flares. They are not well-suited to detecting the low-grade, persistent inflammation characteristic of inflammaging, because they fluctuate with daily biological activity and only change significantly when disease has already developed. A glycan-based biological age test such as GlycanAge is specifically designed to measure chronic systemic inflammation rather than acute inflammatory events. Read our guide to blood tests for inflammation for a full comparison.

How does GlycanAge measure chronic inflammation?

GlycanAge measures biological age by analyzing the glycans attached to IgG antibodies in a blood sample. The test produces a glycan profile expressed through five indexes — Glycan Shield, Glycan Youth, Glycan Mature, Glycan Median, and Glycan Bisection, which together reflect the balance between pro- and anti-inflammatory immune activity. This profile is compared against a healthy population baseline aged 20 to 80 to calculate biological age. Results are typically available within two to three weeks of sample collection.

Can chronic inflammation be reduced?

Yes. Chronic inflammation is a modifiable biological state responsive to lifestyle interventions including diet, exercise, stress management, sleep optimization, and in some cases pharmacological or hormonal therapies. Because GlycanAge measures IgG glycosylation, which renews approximately every three weeks, meaningful changes in biological age can be detected within three to six months of a sustained intervention. Clinical studies have shown that regular moderate exercise, caloric restriction, and hormone therapy can each produce measurable reductions in glycan-based biological age.

External sources:

• https://www.cell.com/cell/fulltext/S0092-8674(22)01377-0 — López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243–278.

• https://pubmed.ncbi.nlm.nih.gov/23382691/ — Lauc G, Huffman JE, Pučić M, Zgaga L, Adamczyk B, Mužinić A, et al. Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers. PLoS Genet. 2013;9(1):e1003225.

• https://www.nature.com/articles/nature01323 — Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–874.